PharmaShots | Incisive News in 3 Shots

Subscribe Now

HFrEF

Boehringer Ingelheim and Eli Lilly's Jardiance (empagliflozin) Receive the US FDA's Approval for the Treatment of Heart Failure with Reduced Ejection Fraction

Boehringer Ingelheim and Eli Lilly's Jardiance (empagliflozin) Receive the US FDA's Approval for the Treatment of Heart Failure wi...

August 19, 2021

Boehringer Ingelheim and Eli Lilly Report Results of Jardiance in Adults with HFrEF Regardless of Chronic Kidney Disease Status

Boehringer Ingelheim and Eli Lilly Report Results of Jardiance in Adults with HFrEF Regardless of Chronic Kidney Disease Status

October 26, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us